Bristol Myers Squibb (BMY)
(Delayed Data from NYSE)
$43.36 USD
-0.67 (-1.52%)
Updated May 20, 2024 04:00 PM ET
After-Market: $43.41 +0.05 (0.12%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth B Momentum A VGM
Brokerage Reports
0 items in cart
Bristol Myers Squibb Company [BMY]
Reports for Purchase
Showing records 281 - 300 ( 439 total )
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Countdown to EASL Begins: Presentation Titles Released
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Company: Bristol Myers Squibb Company
Industry: Large Cap Pharmaceuticals
Immuno-Oncology Key Opinion Leader Conference Call Recap
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R